1. Journal of Microbiology, Immunology and Infection
Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4– 48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo- controlled study 
Yi-Jie Wu, Wei-Fong Wu, Chia-Wei Hung, Ming-Shiu Ku, Pei-Fen Liao, Hai-Lun Sun, Ko-Hsiu Lu, Ji-Nan Sheu, Ko-Huang Lue 
Journal of Microbiology, Immunology and Infection 
DOI: /j.jmii
Copyright © Terms and Conditions

2. Figure 1
Trial profile showing patient population analyzed for efficacy of the probiotics.
Journal of Microbiology, Immunology and Infection DOI: ( /j.jmii )
Copyright © Terms and Conditions

3. Figure 2
The comparison of Scoring of Atopic Dermatitis between the treatment groups during treatment in the intent-to-treat population and per-protocol population. * Statistically significant. Statistical method: paired t test (within group). ITT = intent-to-treat; LR = Lactobacillus rhamnosus; Pbo = placebo; PP = per-protocol; SCORAD=Scoring of Atopic Dermatitis.
Journal of Microbiology, Immunology and Infection DOI: ( /j.jmii )
Copyright © Terms and Conditions

4. Figure 3
The comparison of Scoring of Atopic Dermatitis items between the treatment groups during treatment in the intent-to-treat population and per-protocol population. * Statistically significant. Statistical method: paired t test (within group). ITT = intent-to-treat; LR = Lactobacillus rhamnosus; Pbo = placebo; PP = per-protocol.
Journal of Microbiology, Immunology and Infection DOI: ( /j.jmii )
Copyright © Terms and Conditions